• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

75岁以上无症状参与者的结肠镜监测结果。

Surveillance colonoscopy findings in asymptomatic participants over 75 years of age.

作者信息

Agaciak Madelyn, Wassie Molla M, Simpson Kalindra, Cock Charles, Bampton Peter, Fraser Robert, Symonds Erin L

机构信息

Department of Medicine, College of Medicine and Public Health Flinders University Bedford Park South Australia Australia.

Flinders University, College of Medicine and Public Health Flinders Health and Medical Research Institute, Adelaide Bedford Park South Australia Australia.

出版信息

JGH Open. 2024 May 1;8(5):e13071. doi: 10.1002/jgh3.13071. eCollection 2024 May.

DOI:10.1002/jgh3.13071
PMID:38699472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11062249/
Abstract

BACKGROUND AND AIM

Surveillance colonoscopy for colorectal cancer (CRC) is generally not recommended beyond 75 years of age. The study determined incidence and predictors of advanced adenoma and CRC in older individuals undergoing surveillance colonoscopy.

METHODS

This was a retrospective cohort study of asymptomatic older participants (≥75 years), enrolled in a South Australian CRC surveillance program who underwent colonoscopy (2015-2020). Clinical records were extracted for demographics, personal or family history of CRC, comorbidities, polypharmacy, and colonoscopy findings. The associations between clinical variables and advanced adenoma or CRC at surveillance were assessed with multivariable Poisson regression analysis.

RESULTS

Totally 698 surveillance colonoscopies were analyzed from 574 participants aged 75-91 years (55.6% male). The incidence of CRC was 1.6% (11/698), while 37.9% (260/698) of procedures had advanced adenoma detected. Previous CRC (incidence rate ratio [IRR] 5.9, 95% CI 1.5-22.5), age ≥85 years (IRR 5.8, 95% CI 1.6-20.1) and active smoking (IRR 4.9, 95% CI 1.0-24.4) were independently associated with CRC diagnosis, while advanced adenoma at immediately preceding colonoscopy (IRR 1.6, 95% CI 1.3-2.0) and polypharmacy (IRR 1.2, 95% CI 1.0-1.5) were associated with advanced adenoma at surveillance colonoscopy in asymptomatic older participants (≥75 years).

CONCLUSION

Advanced neoplasia was found in more than one third of the surveillance procedures completed in this cohort. Continuation of surveillance beyond age 75 yeasrs may be considered in participants who have previous CRC or are active smokers (provided they are fit to undergo colonoscopy). In other cases, such as past advanced adenoma only, the need for ongoing surveillance should be considered alongside participant preference and health status.

摘要

背景与目的

一般不建议75岁以上人群进行结直肠癌(CRC)监测性结肠镜检查。本研究确定了接受监测性结肠镜检查的老年个体中进展性腺瘤和CRC的发生率及预测因素。

方法

这是一项对南澳大利亚CRC监测项目中无症状老年参与者(≥75岁)进行的回顾性队列研究,这些参与者在2015年至2020年期间接受了结肠镜检查。提取临床记录中的人口统计学信息、CRC个人或家族史、合并症、多种药物治疗情况以及结肠镜检查结果。采用多变量泊松回归分析评估临床变量与监测时进展性腺瘤或CRC之间的关联。

结果

共分析了574名年龄在75至91岁(男性占55.6%)参与者的698次监测性结肠镜检查。CRC的发生率为1.6%(11/698),而37.9%(260/698)的检查发现了进展性腺瘤。既往CRC(发病率比[IRR] 5.9,95%可信区间[CI] 1.5 - 22.5)、年龄≥85岁(IRR 5.8,95% CI 1.6 - 20.1)和当前吸烟(IRR 4.9,95% CI 1.0 - 24.4)与CRC诊断独立相关,而前次结肠镜检查时的进展性腺瘤(IRR 1.6,95% CI 1.3 - 2.0)和多种药物治疗(IRR 1.2,95% CI 1.0 - 1.5)与无症状老年参与者(≥75岁)监测性结肠镜检查时的进展性腺瘤相关。

结论

在该队列完成的超过三分之一的监测检查中发现了高级别肿瘤。对于既往有CRC或当前吸烟的参与者(前提是他们适合接受结肠镜检查),可考虑在75岁以后继续进行监测。在其他情况下,如仅既往有进展性腺瘤,应结合参与者的意愿和健康状况考虑是否需要持续监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc87/11062249/5633e0ca0609/JGH3-8-e13071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc87/11062249/5633e0ca0609/JGH3-8-e13071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc87/11062249/5633e0ca0609/JGH3-8-e13071-g001.jpg

相似文献

1
Surveillance colonoscopy findings in asymptomatic participants over 75 years of age.75岁以上无症状参与者的结肠镜监测结果。
JGH Open. 2024 May 1;8(5):e13071. doi: 10.1002/jgh3.13071. eCollection 2024 May.
2
Surveillance Colonoscopy Findings in Older Adults With a History of Colorectal Adenomas.老年人有结直肠腺瘤病史的结肠镜监测结果。
JAMA Netw Open. 2024 Apr 1;7(4):e244611. doi: 10.1001/jamanetworkopen.2024.4611.
3
Faecal immunochemical test mitigates risk of delayed colonoscopy in people with elevated risk of colorectal neoplasia.粪便免疫化学检测可降低结直肠肿瘤高危人群延迟结肠镜检查的风险。
J Gastroenterol Hepatol. 2022 Jun;37(6):1067-1075. doi: 10.1111/jgh.15823. Epub 2022 Mar 16.
4
Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence.结肠镜检查腺瘤发现与长期结直肠癌发病率的关系。
JAMA. 2018 May 15;319(19):2021-2031. doi: 10.1001/jama.2018.5809.
5
Low Incidence of Colorectal Advanced Neoplasia During Surveillance in Individuals with a Family History of Colorectal Cancer.有结直肠癌家族史个体在监测期间结直肠高级别瘤变的低发病率
Dig Dis Sci. 2023 Nov;68(11):4243-4251. doi: 10.1007/s10620-023-08053-6. Epub 2023 Sep 8.
6
Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance.基线结肠镜检查结果与结肠镜筛查监测队列中 10 年结局的相关性。
Gastroenterology. 2020 Mar;158(4):862-874.e8. doi: 10.1053/j.gastro.2019.07.052. Epub 2019 Jul 31.
7
The influence of the surveillance time interval on the risk of advanced neoplasia after non-advanced adenoma removal.监测时间间隔对非进展性腺瘤切除术后进展期肿瘤发生风险的影响。
Med J Aust. 2021 Nov 15;215(10):465-470. doi: 10.5694/mja2.51222. Epub 2021 Aug 12.
8
Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance Program.多次阴性粪便免疫化学检测可降低结肠镜监测计划中高级别腺瘤的风险。
Clin Gastroenterol Hepatol. 2023 Aug;21(9):2389-2398.e2. doi: 10.1016/j.cgh.2022.12.024. Epub 2023 Jan 5.
9
The significance of the small adenoma: a longitudinal study of surveillance colonoscopy in an Australian population.小腺瘤的意义:澳大利亚人群结肠镜监测的纵向研究
Eur J Gastroenterol Hepatol. 2019 May;31(5):563-569. doi: 10.1097/MEG.0000000000001358.
10
Prevalence of adenomatous polyposis in a fecal immunochemical test-based colorectal cancer screening program and risk of advanced neoplasia during follow-up.基于粪便免疫化学试验的结直肠癌筛查计划中腺瘤性息肉的流行情况及随访期间高级别瘤变的风险。
Endoscopy. 2022 Jul;54(7):688-697. doi: 10.1055/a-1660-5353. Epub 2021 Dec 21.

本文引用的文献

1
Colorectal Cancer Screening Receipt Does Not Differ by 10-Year Mortality Risk Among Older Adults.老年人中,10 年死亡率对结直肠癌筛查接受率无影响。
Am J Gastroenterol. 2024 Feb 1;119(2):353-363. doi: 10.14309/ajg.0000000000002536. Epub 2023 Oct 27.
2
Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old.结肠镜检查阴性 76-85 岁可筛查人群中,10 年后结直肠癌发病风险和结直肠癌死亡率。
Cancer Epidemiol Biomarkers Prev. 2023 Jan 9;32(1):37-45. doi: 10.1158/1055-9965.EPI-22-0581.
3
Comparison of surgical and oncologic outcomes in very elderly patients (≥ 80 years old) and elderly (65-79 years old) colorectal cancer patients: a propensity score matching.
非常老年患者(≥80 岁)和老年患者(65-79 岁)结直肠癌患者的手术和肿瘤学结局比较:倾向评分匹配。
BMC Gastroenterol. 2022 Apr 25;22(1):205. doi: 10.1186/s12876-022-02277-y.
4
Charlson Comorbidity Index in Predicting Poor Clinical Outcomes and Mortality in Patients with COVID-19.查尔森合并症指数在预测新冠病毒疾病患者不良临床结局及死亡率中的应用
Turk Thorac J. 2022 Mar;23(2):145-153. doi: 10.5152/TurkThoracJ.2022.21076.
5
Faecal immunochemical test mitigates risk of delayed colonoscopy in people with elevated risk of colorectal neoplasia.粪便免疫化学检测可降低结直肠肿瘤高危人群延迟结肠镜检查的风险。
J Gastroenterol Hepatol. 2022 Jun;37(6):1067-1075. doi: 10.1111/jgh.15823. Epub 2022 Mar 16.
6
Association of Polypharmacy with Colorectal Cancer Survival Among Older Patients.多药联用与老年患者结直肠癌生存的关联。
Oncologist. 2021 Dec;26(12):e2170-e2180. doi: 10.1002/onco.13961. Epub 2021 Sep 20.
7
Practice Patterns and Predictors of Stopping Colonoscopy in Older Adults With Colorectal Polyps.老年结直肠息肉患者结肠镜检查终止的实践模式及预测因素
Clin Gastroenterol Hepatol. 2022 May;20(5):e1050-e1060. doi: 10.1016/j.cgh.2021.06.041. Epub 2021 Jun 30.
8
Association of Screening Lower Endoscopy With Colorectal Cancer Incidence and Mortality in Adults Older Than 75 Years.75 岁以上成年人中,结肠镜筛查与结直肠癌发病率和死亡率的关联。
JAMA Oncol. 2021 Jul 1;7(7):985-992. doi: 10.1001/jamaoncol.2021.1364.
9
The impact of coronavirus disease 2019 on surveillance colonoscopies in South Australia.2019年冠状病毒病对南澳大利亚州监测结肠镜检查的影响。
JGH Open. 2021 Mar 9;5(4):486-492. doi: 10.1002/jgh3.12525. eCollection 2021 Apr.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.